{
    "Orphapacket": {
        "ORPHApacketId": "519",
        "creationDate": "2024-07-01 09:48:26",
        "version": "1.3.29 / 4.1.7 [2023-08-02] (orientdb version)",
        "copyright": "Orphanet (c) 2024",
        "ORPHAcode": "519",
        "Label": "Acute myeloid leukemia",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_519",
        "DisorderType": {
            "value": "Clinical group",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377794"
        },
        "Synonyms": [
            {
                "Synonym": "AML"
            },
            {
                "Synonym": "Acute myelogenous leukemia"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "601626",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation. All of them are characterized by clonal expansion of myeloid blasts. They manifest by fever pallor anemia hemorrhages and recurrent infections."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "171895",
                        "Label": "Myeloid hemopathy"
                    }
                ]
            }
        ],
        "Childs": [],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "17019734[PMID]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "European Medicines Agency 2018[INST]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-5 / 10 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Lifetime Prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-5 / 10 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "Institut National du Cancer 2013[INST]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "France"
                }
            },
            {
                "Prevalence": {
                    "Source": "24039451[PMID]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Denmark"
                }
            },
            {
                "Prevalence": {
                    "Source": "National Cancer institute 2010[INST]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "United States"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "All ages"
                }
            ]
        }
    }
}